Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest Tissue plasminogen activator Stories

2010-02-26 10:46:00

Study highlights: -- The antiplatelet drug cilostazol was better than aspirin in preventing a recurrent stroke in a Japanese trial. -- Compared to patients taking aspirin, patients taking the drug were less likely to have new ischemic stroke or develop bleeding requiring hospitalization. -- Cilostazol is used to reduce leg pain associated with peripheral vascular disease in the United States. SAN ANTONIO, Feb. 26 /PRNewswire-USNewswire/ -- The antiplatelet drug cilostazol -- used in the...

2010-02-25 19:06:00

Results presented today at the American Heart Association's International Stroke Conference SEATTLE, Feb. 25 /PRNewswire-USNewswire/ -- David Newell, M.D., co-executive director of the Swedish Neuroscience Institute (SNI) in Seattle today presented results of a groundbreaking study of 33 patients with spontaneous intracerebral hemorrhage who were screened for inclusion in a SNI clinical study known as 'SLEUTH' (Safety of Lysis with Ultrasound in the Treatment of Intracerebral and...

2010-02-25 12:47:07

Techniques that keep brain arteries open (intracranial stenting) or inject clot-busting drugs directly to the brain (intra-arterial tPA) may be more effective than other urgent ischemic stroke treatments, researchers said at the American Stroke Association's International Stroke Conference 2010. In a study of 1,056 severe stroke patients treated with one or more therapies within eight hours of symptom onset, blood flow was restored in 76 percent of stented patients and 72 percent of those...

2010-02-24 11:08:02

Clot-busting treatment should be considered for patients last seen healthy within a few hours before having a stroke, according to research presented at the American Stroke Association's International Stroke Conference 2010. A Canadian study analyzed outcomes of clot-busting drugs given to patients based on when they were last seen in their usual state of health ("time last seen normal") compared to patients who had someone witness the start of their stroke symptoms. The "time last seen...

2010-02-22 09:16:36

Findings from the first 1 million patients Acute stroke care and clinical outcomes have improved significantly at hospitals participating in the American Heart Association/American Stroke Association's Get With The Guidelines"“Stroke program, according to a large study in Circulation: Cardiovascular Quality and Outcomes, a journal of the American Heart Association. To better characterize contemporary stroke patients and determine the impact of Get With The Guidelines"“Stroke...

2010-02-08 15:00:00

American Heart Association rapid access journal report DALLAS, Feb. 8 /PRNewswire-USNewswire/ -- Age-related gaps in care and outcomes for stroke patients are diminishing as hospitals improve adherence to evidence-based treatments of the American Heart Association/American Stroke Association's Get With The Guidelines-Stroke initiative, according to a new study in Circulation: Journal of the American Heart Association. "The burden of ischemic stroke is disproportionately borne by older...

2010-01-11 20:41:20

Stroke patients admitted to the hospital on the weekend appear more likely to receive the clot-dissolving medication tissue plasminogen activator than patients admitted during the week, according to a report in the January issue of Archives of Neurology, one of the JAMA/Archives journals. However, stroke death rates appear similar among weekend and weekday admissions. "Although hospitals operate around the clock every day of the year, there are inevitable staffing differences during shifts,...

2009-12-02 12:09:00

PASADENA, Calif., Dec. 2 /PRNewswire-USNewswire/ -- Huntington Memorial Hospital's stroke program has received the Gold Seal of Approval from the Joint Commission, designating the hospital a primary stroke center. This means Huntington will join the network of "approved stroke center" hospitals throughout Los Angeles County. "This is a significant milestone for the hospital, but more important, a wonderful benefit for Pasadena and its surrounding communities," said Arbi Ohanian, M.D.,...

2009-11-17 07:00:00

WALTHAM, Mass., Nov. 17 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that sales of agents to treat acute ischemic stroke will remain relatively flat over the next decade, increasing from $360 million in 2008 to $450 million in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan. The new Pharmacor report entitled Acute Ischemic Stroke finds that broadening the use...

2009-10-12 16:45:00

WINFIELD, Ill., Oct. 12 /PRNewswire-USNewswire/ -- Central DuPage Hospital (http://www.cdh.org) (CDH), in Winfield, Ill., is the only Illinois hospital that will participate in a national investigational trial to test the effectiveness of a device that might extend the traditional stroke treatment window from three hours to an unprecedented 24 hours. CDH is one of only six hospitals in the U.S. making the research trial available to acute ischemic stroke patients. The investigational...